Board of Directors

Michael Donnelly, Chairman
Michael is Chairman of Growcorp Group Ltd. Prior to Growcorp, he was Vice President and General Manager of a medical products company in Cincinnati, Ohio from 1996-1998, Vice President of IEP Group Research Triangle Park, NC from 1993-1996, Professor of Pediatrics, College of Medicine, University of Cincinnati, Ohio, and Director of Bioengineering Research at the Perinatal Research Institute, Cincinnati, Ohio from 1986-1996. Michael sits on the Boards of Growcorp Group, Growcorp (GP), Merrion Pharmaceuticals Ltd., Gas Sensor Solutions, Fluorocap and Pharmatrin, Orakine, North Wall General Partners, Neutekbio, Irish Venture capital Association and Irish Biotechnology Association and is the Managing Partner of the European Bioscience Fund.

Harry Stratford, Non-Executive and Chair of the Compensation, Nominating and Governance Committee
Harry is the founder and executive chairman of Stratford Healthcare founded in 2008. Harry has over 36 years experience in the pharmaceutical industry. He has built two successful publicly listed pharmaceutical companies from the ground up. Prior to Stratford Healthcare's foundation, Harry was the founder, CEO and Executive Chairman of Prostrakan Plc, the UK International specialty pharmaceutical company. He founded Shire Pharmaceuticals in 1986 and was CEO for almost a decade. Harry holds a BSc. in Chemistry from the University of London and was awarded an OBE in 2007 New Year's Honours list for his contribution to the Scottish Life Sciences Industry.

	Chair of the Nominating and Governance Committee
	Chair of the Compensation Committee

Michael J. McKenna, PhD, Non Executive
Michael served as Chairman from February 2008 to February 2009, as Merrion's Chief Executive Officer from April 2004 to February 2008, and on the board of directors since April 2004. From September 1999 to March 2004, Michael served as vice president of science and technology at A.M. Pappas & Associates, LLC, a life sciences venture development company. Previously, he owned and operated Pharmaceutical Consulting Services, advising the biopharmaceutical industry in drug development and drug safety. Prior to this he was Vice President, Drug Development at Parke Davis. Michael also held numerous scientific and managerial positions in the toxicology laboratories of The Dow Chemical Company and Parke Davis. Michael received a B.A. in English from St. John Fisher College and a PhD in Toxicology from the University of Rochester School of Medicine and Dentistry.

Anthony Carragher, Non-Executive
Anthony has his own consultancy and advisory business that focuses primarily on International financial and property investments. He is also a director of Eurocommerce, Growcorp, and The Vaults. Anthony is a qualified chartered accountant and has spent over 15 years in the corporate finance and investment area. He is also CFO to a major Irish charitable organisation.

Member of the Audit Committee

Fintan Maher, Non-Executive
Fintan is a Partner with Macquarie Private Bank in Sydney since 2010. Prior to this he was the Managing Director of Northwall General Partner Ltd., the General Partner of Growcorp Lifescience Limited Partnership, an investment fund focused on life science investments. He held this position since October 2004. He has 20 years Investment experience covering Private Wealth Management, Private Equity and Investment Management. From 1999 to 2004 Fintan was the Investment Manager for Irelandia Investments Ltd., the family office of the Ryan Family. He previously held a series of senior roles in Investment Management in the US and Ireland. Fintan sits on the Boards of Growcorp Group, Growcorp (GP), North Wall General Partner Ltd., Merrion Pharmaceuticals Ltd., Gas Sensor Solutions, Orakine and nEUtekbio. Fintan earned a Bachelor of Commerce from University College Dublin, and is a member of The Society of Investment Analysts in Ireland (SIAI) a member society of the CFA Institute.

	Member of the Audit Committee
	Member of the Nominating and Governance Committee